@article{dd883650cc6e4ad2a9aff8cf4ce9deb4,
title = "Pyridostigmine for treatment of neurogenic orthostatic hypertension: A follow-up survey study",
abstract = "We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients' satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.",
keywords = "Orthostatic hypotension, Pyridostigmine",
author = "Paola Sandroni and Opfer-Gehrking, {Tonette L.} and Wolfgang Singer and Low, {Phillip A.}",
note = "Funding Information: P. Sandroni ( ) · T. L. Opfer-Gehrking · W. Singer · P. A. Low Autonomic Disorders Center Mayo Clinic 200 First Street SW Rochester (MN) 55905, USA Tel.: +1-507/538-1037 Fax: +1-507/284-4074 E-Mail: psandroni@mayo.edu This study was supported in part from grants from the National Institutes of Health, Bethesda, MD: 5 K23 RR15537 (Dr. Sandroni),NS3 2352,NS4 4233 NS4 3364 (Dr. Low), and Mayo GCRC grant M01-RR00585",
year = "2005",
month = feb,
doi = "10.1007/s10286-005-0225-3",
language = "English (US)",
volume = "15",
pages = "51--53",
journal = "Clinical Autonomic Research",
issn = "0959-9851",
publisher = "D. Steinkopff-Verlag",
number = "1",
}